Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Japan's Health"


7 mentions found


AdvertisementTokyo is introducing a four-day workweek to help boost fertility rates and support women. It's also rolling out a policy to allow parents to sacrifice salary in exchange for shorter days. As Japan grapples with a record-low fertility rate, Toyko's government is trying new strategies to try to encourage women to have more children. Japan's fertility rate sank to a record low of 1.2 in 2023, far below the global replacement rate of about 2.1. Meanwhile, other Asian countries grappling with similar declines in marriage and fertility rates have introduced their own creative methods to try to help single people find a match.
Persons: Yuriko Koike, Koike, Fumio Kishida Organizations: Tokyo Metropolitan Government, Japan Times, Japan's Health, Welfare Ministry, Monetary Fund Locations: Tokyo, Japan, Toyko, Korea
Read previewIn Japan, cases of an uncommon but deadly bacterial infection have spiked in recent months, concerning health officials, the Washington Post reported. At least 77 deaths have been reported due to these STSS infections, with most fatal cases occurring in people over 50. Since the coronavirus pandemic, health officials worldwide have expressed concern about increasing bacterial and viral infection rates. In 2022, UK health officials reported 19 child deaths due to group-A streptococcal infections, the same bacteria that causes STSS. Vaccines could help prevent the spread of these rare but potentially deadly bacterial infections, health experts said.
Persons: , Steer, we've, Andrew Steer Organizations: Service, Washington Post, Japan's Health Ministry, Business, CDC, Murdoch Children's Research Locations: Japan, Melbourne, Australia
The shift in business strategy is due to Japan's declining birth rate and aging population. AdvertisementA Japanese diaper maker announced that it will stop producing diapers for babies and will, instead, focus on catering to the country's aging population with adult nappies. Related storiesConcerns over the implications of a declining birth rate have led to Japanese officials sounding the alarm. AdvertisementLow birth rates and an aging population risk dramatically shrinking Japan's population, which is estimated to fall by about 30% to 87 million by 2070, The Guardian reported. Oji Holdings' pivot due to shifting demographics mirrors a similar move made by Unicharm, Japan's biggest diaper maker, over a decade ago.
Persons: , Yoshimasa Hayashi, Fumio Kishida, It's, Unicharm Organizations: Service, Holdings, BBC News, Health, Welfare Ministry, United Nations Population Division, Guardian, Bloomberg Locations: Japan
Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. But Jim Cramer said Thursday that he expects yields to peak soon, which should bolster the stock market. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Persons: Jim Cramer, Jim, Stanley Black, Decker, Mizuho, Jim Cramer's Organizations: CNBC, Treasury, Procter & Gamble, Broadcom, GE HealthCare Mizuho, GE HealthCare, Mizuho, Costco, TJX, Club, Costco Wholesale
TOKYO (AP) — Japan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and U.S. pharmaceutical companies. It's the first drug for treatment of the disease in a country with a rapidly aging population. Developed by Japanese drugmaker Eisai Co. and U.S. biotechnology firm Biogen Inc., the drug's approval in Japan comes two months after it was endorsed by the U.S. Food and Drug Administration. Eisai said it will conduct a post-marketing special use survey in all patients administered the drug until enough data is collected from unspecified number of patients under Japanese health ministry procedures. Eisai is committed to delivering Leqembi to people who need it and their families “as a new treatment,” said Haruo Naito, the company’s CEO.
Persons: Fumio Kishida, Kishida, Eisai, Leqembi, , Haruo Naito Organizations: TOKYO, Biogen Inc, U.S . Food, Drug Administration, Kyodo Locations: Japan
Japanese startup Exit will quit your job and confront your boss for you for $144. Employers "try to make you ashamed and guilty that you quit your job in less than three years," the cofounder told Al Jazeera. Japanese culture — with deep-rooted practices for lifetime employment — sees success as a long-term commitment. That's the exact sentiment one company is capitalizing on: For 20,000 Japanese yen, or $144, a Japanese startup called Exit will quit your job for you. Exit's story began in 2017 when cofounder Toshiyuki Niino was trying to quit a job he was unhappy at, Al Jazeera reported.
Persons: Al Jazeera, , Toshiyuki Niino, Niino, Yuichiro Okazaki Organizations: Employers, Service Locations: Al, Al Jazeera, Japan
For more than two years, overseas travelers have had to quarantine upon arrival in China because of Covid restrictions. The U.S. government is considering imposing new Covid rules for travelers from China, officials said, citing concerns over virus-related data released by the Chinese government. The officials pointed to Japan's recent measures which require a negative Covid test for travelers arriving from mainland China from Dec. 30 – as China faces a sharp surge in infections nationwide following an abrupt reopening. Travelers from China without a valid vaccination certificate will also be required to take a pre-departure test, the notice from Japan's health ministry added. The measures will not apply to those traveling from Hong Kong and Macao, according to the notice.
Total: 7